Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 16/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2657715 | 1.00 | GCK (0.68) | GCKTDP1PKMALDH1A1 | |
| SCHEMBL2655792 | 0.90 | GCK (0.66) | GCKALDH1A1 | |
| SCHEMBL3556353 | 0.90 | GCK (0.66) | GCKALDH1A1 | |
| SCHEMBL2654934 | 0.88 | GCK (0.64) | GCKALDH1A1 | |
| SCHEMBL2655278 | 0.87 | GCK (0.62) | GCKTDP1ALDH1A1 | |
| SCHEMBL2647374 | 0.85 | GCK (0.71) | GCKALDH1A1 | |
| SCHEMBL2647371 | 0.85 | GCK (0.71) | GCKALDH1A1 | |
| SCHEMBL2657205 | 0.85 | GCK (0.64) | GCKALDH1A1 | |
| SCHEMBL3570329 | 0.85 | GCK (0.64) | GCKALDH1A1 | |
| SCHEMBL27727420 | 0.85 | GCK (0.51) | GCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795257-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-09-14 | — | — | US | claimed |
| US-20080318948-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-12-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318948-A1 | Organic Compounds | GCK, GCKR, SLC2A2 | GCK 1/4885TDP1 3142/4885PKM 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.